Kopetz, Scott ;
Grothey, Axel ;
Yaeger, Rona...
Kopetz , S , Grothey , A , Yaeger , R , Van Cutsem , E , Desai , J , Yoshino , T , Wasan , H , Ciardiello , F , Loupakis , F , Hong , Y S , Steeghs , N , Guren , T K , Arkenau , H T , Garcia-Alfonso , P , Pfeiffer , P , Orlov , S , Lonardi , S , Elez , E , Kim , T W , Schellens , J H M , Guo , C , Krishnan , A , Dekervel , J , Morris , V , Ferrandiz , A C , Tarpgaard , L S , Braun , M , Gollerkeri , A , Keir , C , Maharry , K , Pickard , M , Christy-Bittel , J , Anderson , L , Sandor , V & Tabernero , J 2019 , ' Encorafenib, binimetinib, and cetuximab in BRAF V600E–mutated colorectal cancer ' , New England Journal of Medicine , vol. 381 , no. 17 , pp. 1632-1643 . https://doi.org/10.1056/NEJMoa1908075.
,
2019
